• Skip to Content
  • Skip to Main Navigation
  • Skip to Search

Indiana University Indiana University IU

Open Search
  • About
    • Goals
    • Leadership
    • Partners
    • Contact Us
    • Cite the Precision Health Initiative
  • Areas of Focus
    • Disease Research Teams
      • Alzheimer’s Disease
      • Multiple Myeloma
      • Pediatric Sarcomas
      • Triple Negative Breast Cancer
      • Type 2 Diabetes - Diabetes & Pregnancy
      • Undiagnosed Rare Disease
    • Scientific Pillars
      • Cell, Gene, & Immune Therapy
        • Programs
        • Leadership
      • Chemical Biology & Biotherapeutics
        • Programs
        • Leadership
      • Data & Informatics
        • Programs
        • Leadership
      • Genomic Medicine
        • Programs
        • Leadership
      • Psychosocial, Behavioral & Ethics
        • Programs
        • Leadership
      • Regenerative Medicine & Engineering
  • Get Involved
    • Hoosier Moms Study
    • IU Precision Health Consent
    • Person to Person Health Interview Study
    • Total Cancer Care
    • General FAQs
  • News & Multimedia
    • Newsroom
    • Patient stories
    • Podcasts
    • Subscribe to e-newsletter
    • Webinars
  • Progress
  • Careers

Precision Health

  • Home
  • About
    • Goals
    • Leadership
    • Partners
    • Contact Us
    • Cite the Precision Health Initiative
  • Areas of Focus
    • Disease Research Teams
    • Scientific Pillars
  • Get Involved
    • Hoosier Moms Study
    • IU Precision Health Consent
    • Person to Person Health Interview Study
    • Total Cancer Care
    • General FAQs
  • News & Multimedia
    • Newsroom
    • Patient stories
    • Podcasts
    • Subscribe to e-newsletter
    • Webinars
  • Progress
  • Search
  • Careers
  • Home
  • News & Multimedia
  • News
  • Precision Health podcast: How New Drugs Are Developed

Precision Health podcast: How New Drugs Are Developed

Tuesday, May 07, 2019

“It’s been said that developing a drug is not rocket science, it’s actually much, much harder,” said Dan Skovronsky, MD, PhD and Chief Scientific Officer for Eli Lilly and Company.

In this month’s podcast, you will hear how medicines are discovered and made.

Listen to Dan Skovronsky, MD, PhD and Chief Scientific Officer for Eli Lilly and Company discuss the complicated process of drug discovery and development with his medical school classmate, friend and host of Healthcare Triage podcast, IU School of Medicine faculty member and New York Times contributor Aaron E. Carroll, MD.

IU School of Medicine collaborates with Lilly on a variety of projects, including the IU Grand Challenge Precision Health initiative. During the podcast, Skovronsky shares about the importance of research, his gratitude to patients willing to participate in research and Lilly’s foray into RNA medicines.

The Healthcare Triage podcast is sponsored by Indiana University School of Medicine whose mission is to advance health in the state of Indiana and beyond by promoting innovation and excellence in education, research and patient care.

IU School of Medicine is leading Indiana University's first grand challenge, the Precision Health Initiative, with bold goals to cure multiple myeloma, triple negative breast cancer and childhood sarcoma and prevent type 2 diabetes and Alzheimer’s disease.

Listen to the podcast

Precision Health resources

  • Grand Challenges

Indiana University

Accessibility | Privacy Notice | Copyright © 2022 The Trustees of Indiana University